Corient Private Wealth
CLX icon

Corient Private Wealth’s Clorox CLX Stock Holding History

Corient Private Wealth’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38M Sell
23,441
-10,681
-31% -$1.21M ﹤0.01% 1172
2025
Q4 		$3.04M Buy
34,122
+16,338
+92% +$1.77M ﹤0.01% 1301
2025
Q3 		$2.19M Sell
17,784
-3,042
-15% -$378K ﹤0.01% 1020
2025
Q2 		$2.5M Sell
20,826
-4,332
-17% -$578K ﹤0.01% 940
2025
Q1 		$3.7M Sell
25,158
-3,494
-12% -$534K 0.01% 771
2024
Q4 		$4.65M Buy
28,652
+317
+1% +$51.9K 0.01% 722
2024
Q3 		$4.62M Sell
28,335
-872
-3% -$129K 0.01% 776
2024
Q2 		$3.99M Sell
29,207
-2,336
-7% -$324K 0.01% 773
2024
Q1 		$4.83M Sell
31,543
-2,027
-6% -$303K 0.01% 712
2023
Q4 		$4.79M Buy
33,570
+2,230
+7% +$297K 0.01% 705
2023
Q3 		$4.11M Sell
31,340
-213
-0.7% -$32.4K 0.01% 683
2023
Q2 		$5.02M Sell
31,553
-1,927
-6% -$311K 0.01% 634
2023
Q1 		$5.3M Buy
33,480
+6,354
+23% +$953K 0.01% 578
2022
Q4 		$3.81M Buy
+27,126
New +$3.85M 0.01% 558

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Corient Private Wealth's CLX Position: Q1 2026 in Review

Corient Private Wealth reduced its Clorox (CLX) stake by 31% in Q1 2026, selling an estimated $1.21M and leaving 23,441 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Corient Private Wealth first reported a position in CLX in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.3M in Q1 2023. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Corient Private Wealth held 23,441 shares of Clorox worth $2.38M as of Q1 2026.
  • Corient Private Wealth sold 10,681 Clorox shares in Q1 2026, an estimated $1.21M.
  • Clorox made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1172 holding.
  • Corient Private Wealth first reported a position in Clorox in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Clorox position peaked at $5.3M in Q1 2023.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.